A randomized controlled trial showed that GLP-1RAs prevents the decline of cerebral metabolic rate for glucose (CMRglc) in AD, and GLP-1RAs may increase the expression of glucose transporters (e.g., GLUT1) at the blood-brain barrier (BBB) (Gejl et al., 2017)
The graphical abstract is created in BioRender
For anyone with thyroid disease, the combination of new or worsening palpitations plus other symptomssuch as weight loss, tremor, heat intolerance, or anxietywarrants a prompt check of thyroid labs and a conversation with a knowledgeable clinician
(PubMed) Ziegler D, Nowak H, Kempler P, Vargha P, Low PA
Heart failure during total parenteral nutrition recovered by administration of carnitine and selenium
But its origins are the key to its primary function